Answers are grounded in this paper and cite their sources.
Review illuminates synthesis pathways and therapeutic activities of thiazolidinones against non-communicable diseases, suggesting new drug development opportunities.
Thiazolidinones, the saturated analogues of thiazole, are five-membered heterocyclic compounds with sulfur, nitrogen, and a carbonyl group at the fourth carbon. This ring system gives rise to numerous biologically active compounds exhibiting properties such as anticancer, antibacterial, antiviral, antifungal, antidiabetic, antitubercular, and anticonvulsant effects, while maintaining good biocompatibility due to its versatile molecular structure. The unique balance between broad activity and safety stems from the tunable structure of the thiazolidinone framework, which facilitates selective engagement with target biomolecules while minimizing nonspecific cytotoxicity. Owing to their structural versatility and ease of functional modification, they serve as valuable scaffolds in the development of new therapeutic agents. This review illuminates the pathways for synthesis, mechanisms of action against non-communicable diseases, and summarizes the recent advances on therapeutic activities of thiazolidinones to guide the medicinal chemists working on this core in the evolution of clinically active drugs. This study is believed to contribute to the current discussion between many fields working on 4-thiazolidinone, lowering disciplinary barriers and smoothing further advancement towards therapeutic agents
No takes yet. Share an insight, caveat, or question.
Ramzan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: